An Military nurse holds a vial of the Johnson & Johnson vaccine on the FEMA-supported COVID-19 vaccination web site at Valencia State School on
An Military nurse holds a vial of the Johnson & Johnson vaccine on the FEMA-supported COVID-19 vaccination web site at Valencia State School on the primary day the positioning resumed providing the Johnson & Johnson vaccine following the lifting of the pause ordered by the FDA and the CDC as a result of blood clot issues.
Paul Hennessy | LightRocket | Getty Pictures
Lower than half of Individuals are assured within the security of the Johnson & Johnson Covid-19 vaccine after it was quickly halted within the U.S. following studies of a uncommon blood clotting situation in some recipients, based on a brand new survey by the Kaiser Household Basis.
Whereas most individuals are assured in Covid vaccines, generally, simply 46% of survey respondents mentioned they had been no less than considerably assured within the J&J shot, in contrast with 69% who mentioned the identical for each the Pfizer and Moderna vaccines. Kaiser surveyed 2,097 randomly chosen adults ages 18 and older from April 15 via April 29 for the research revealed Wednesday.
The Meals and Drug Administration and Facilities for Illness Management and Prevention on April 13 requested states to quickly halt utilizing J&J’s vaccine “out of an abundance of warning” following studies of uncommon blood clots in six ladies. A CDC panel really helpful the U.S. resume utilizing the vaccine 10 days later, saying the advantages outweigh the dangers.
The J&J information seems to have modified some minds about getting a shot.
One in 5 unvaccinated respondents mentioned the information altered their view about getting the vaccine in a roundabout way, although the precise reactions different, with 7% saying it made them much less prone to need any of the three Covid vaccines, Kaiser discovered. One other 9% mentioned it made them much less prone to need the J&J vaccine however that it did not change their minds in regards to the Pfizer or Moderna pictures.
Nonetheless, the share of respondents who say they’ve obtained a shot elevated considerably from final month’s survey, leaping from 32% to 56%. That determine mirrors information from the CDC, which studies that about the identical share of U.S. adults have obtained one dose or extra.
“The information was widespread, and it actually affected confidence in J&J, however it’s not clear that it had a big effect on whether or not individuals really bought vaccinated or not,” mentioned Dr. Mollyann Brodie, government director of the muse’s public opinion and survey analysis program. “It confirmed for individuals who had been involved about negative effects that there have been negative effects, however we all know that the speedy impact — no less than by way of what individuals advised us — could be very minor by way of demand.”
Ladies had been extra probably than males to say the J&J information modified their minds about getting vaccinated, the Kaiser survey confirmed, significantly Hispanic ladies, 18% of whom mentioned it made them much less prone to need a vaccine in any respect.
The timing of the Johnson & Johnson pause coincides with an general slowdown in U.S. vaccinations. The nation reported a median of two.1 million vaccinations per day over the previous week, CDC information exhibits, down from a peak of three.four million on April 13.
The truth that the nationwide decline in every day pictures occurred through the halt is extra of a coincidence than a direct impact, mentioned Dr. Rupali Limaye, a college member on the Johns Hopkins Bloomberg Faculty of Public Well being. Limaye research vaccine decision-making and has been working with state well being departments through the vaccine rollout.
Whereas the pause on J&J and any ensuing reluctance contributes to the decline considerably, Limaye mentioned the larger issue is that the nation has reached the purpose the place most Individuals who need a vaccine have gotten one.
“I am listening to from states that issues usually are not simply slowing usually due to J&J, however slowing as a result of we have primarily been capable of fulfill demand,” she mentioned.
The Kaiser Basis survey information backs this up. Respondents who mentioned they had been most looking forward to a shot — these already vaccinated or who need it as quickly as attainable — elevated solely barely from the final survey in March, from 61% to 64%. The share who need to “wait and see” earlier than getting vaccinated, which had been shrinking in measurement, remained about the identical.
“We’re at a stage within the vaccination effort the place all of the keen of us are already vaccinated or within the course of,” Brodie mentioned. “We’re now turning to the people who find themselves hesitant, with methods wanted to succeed in a whole lot of totally different individuals.”